Post Subject #42   I found this jondoeuk 05/19/22 04:00:53 PM #41   EHA PR https://www.globenewswire.com/news-release/2022/05/12/2442194/0/en/Autolu jondoeuk 05/12/22 02:23:42 PM #40   1105: CAR-T Cells Engineered to Express a FAS-CD40 jondoeuk 05/02/22 05:41:55 PM #39   ASGCT titles: jondoeuk 04/29/22 07:23:57 PM #38   Also, clinical data from AUTO4*. jondoeuk 04/17/22 06:21:53 PM #37   Additional clinical data at the EHA Congress, June: jondoeuk 04/17/22 06:19:30 PM #36   Management will host a conference call and webcast jondoeuk 12/07/21 06:15:03 PM #35   I like what I see here Patience from Elgordo84 11/16/21 11:12:50 AM #34   New preclinical data https://www.globenewswire.com/news-release/2021/11/10/23313 jondoeuk 11/10/21 10:27:49 AM #33   ASH abstracts jondoeuk 11/04/21 02:39:55 PM #32   Two ways to potentially improve the activity of jondoeuk 08/12/21 03:06:02 PM #31   The company has announced that it has received jondoeuk 08/09/21 12:57:04 PM #30   They have filed for a $300M mixed shelf jondoeuk 08/07/21 09:01:58 PM #29   The company announced an agreement with MRNA, granting jondoeuk 08/05/21 01:02:39 PM #28   Link https://wsw.com/webcast/blair59/panel1/2155736 jondoeuk 07/11/21 01:23:35 PM #27   Dr. Itin, will participate in a panel discussion jondoeuk 07/11/21 01:22:47 PM #26   As of the data cut-off date of May jondoeuk 06/11/21 02:40:53 PM #25   AUTO1 CAR-T cells from pediatric ALL patients who jondoeuk 05/25/21 06:58:21 PM #24   So far, so good. If this holds up, jondoeuk 05/14/21 04:51:17 PM #23   * * $AUTL Video Chart 05-12-2021 * * ClayTrader 05/12/21 04:40:09 PM #22   Wells Fargo Biotech Cell and Gene Therapy Companion stockguard 04/05/21 11:07:07 AM #21   They are now working on ways to further jondoeuk 03/20/21 09:09:02 PM #20   Adding Pennybuster 02/18/21 09:12:48 PM #19   Both lead assets (AUTO1 and AUTO3) have shown jondoeuk 01/20/21 10:29:16 PM #18   JP Morgan webcast https://jpmorgan.metameetings.net/events/healthcare21/sessions jondoeuk 01/20/21 10:23:09 PM #17   I see you are the Lone Ranger here. creakyhottie 11/28/20 10:18:37 PM #16   ASH Investor Call https://edge.media-server.com/mmc/p/6a46f2mv jondoeuk 11/25/20 07:37:45 PM #15   A new paper (AUTO6) https://stm.sciencemag.org/content/12/571/eabd6169 jondoeuk 11/25/20 02:54:24 PM #14   ASH abstracts jondoeuk 11/04/20 07:01:27 PM #13   ESMO webcast https://services.choruscall.com/links/autl200918.html jondoeuk 09/18/20 05:08:11 PM #12   AUTO3 is a first-in-class anti-CD19/22 CAR-T with novel jondoeuk 06/01/20 01:15:21 PM #11   AACR II: AUTO6NG https://www.abstractsonline.com/pp8/#!/9045/presentation/7894 jondoeuk 05/15/20 09:18:03 PM #10   EHA: AUTO1 https://library.ehaweb.org/eha/2020/eha25th/294939/claire.roddie.allcar19.updated.data.us jondoeuk 05/15/20 09:15:04 PM #9   The FDA has accepted the IND application for jondoeuk 04/22/20 09:10:20 PM #8   Vector supply https://pipelinereview.com/index.php/2020030973972/More-News/MolMe jondoeuk 03/13/20 06:40:13 PM #7   J.P. Morgan webcast https://jpmorgan.metameetings.net/events/hc20/sessions/29708 jondoeuk 01/26/20 03:11:05 PM #6   Here is a link to the ASH investor jondoeuk 12/09/19 04:05:56 PM #5   Here is the link to the ASH Data jondoeuk 12/08/19 01:34:37 PM #4   The company has inked an agreement with Noile-Immune jondoeuk 11/16/19 12:59:49 PM #3   The AUTO6NG product consists of three distinct populations jondoeuk 11/16/19 12:57:15 PM #2   A new(ish) paper https://www.nature.com/articles/s41591-019-0549-5 jondoeuk 10/24/19 04:49:00 PM #1   SITC (P146) AUTO6NG: Next generation GD2-targeting CAR T-cell jondoeuk 10/01/19 06:27:35 PM Post Subject

© 2022 InvestorsHub.com, Inc.